Skip to content

Floriphar

Active
Public limited companyfounded 199927 yrs activeAllée André Delvaux 6, 1410 Waterloo, BelgiumKBO/BCE: BE 0464.947.130
Summary

Floriphar has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€36,782) and a net result of -€303. Equity is shrinking by ~18.1% per year across the filed fiscal years. Its solvency ranks better than 5% of 2774 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisWatch ReportCompare
FloripharActiveChecked score 53/100
Risk analysis ReportCompare

Overview

Activity
Medical imaging and medical laboratories
NACE 86910NACE 85141NACE 86901
1 site
Size
€52,979turnover 2025
Equity
-€36,782
Loss
-€303
Financial health
53 Fair Checked score 2025
Bankruptcy chance 12 m
0.1%
Structure
Accounts filed 15 d late0 of 6 deeds read
Why 53Capped at 59: negative equity- Negative equity -€36,782+ Sector Human health activities (NACE 86)+ Size: turnover €52,979, total assets €113,104+ Liquidity: current ratio 0.75, cash €96,832Show the evidence

Checked score

Score 2025
53 / 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 12% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Negative equity caps the score at 59. Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency 0=
equity -32.5% of total assets
Liquidity 50=
short-term debt 132.5% · cash 85.6%
Profitability 20-20
return on assets -0.3%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,682 companies)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● 0.0% vs 11-2024 01-2025: 0.3%▼ -12.4% vs 12-2024 02-2025: 0.3%● 0.0% vs 01-2025 03-2025: 0.4%▲ +11.8% vs 02-2025 04-2025: 0.4%● 0.0% vs 03-2025 05-2025: 0.3%▼ -7.8% vs 04-2025 06-2025: 0.3%▼ -0.9% vs 05-2025 07-2025: 0.4%▲ +12.4% vs 06-2025highest value 08-2025: 0.3%▼ -20.0% vs 07-2025 09-2025: 0.3%● 0.0% vs 08-2025 10-2025: 0.3%● 0.0% vs 09-2025 11-2025: 0.3%▼ -3.6% vs 10-2025 12-2025: 0.3%● 0.0% vs 11-2025 01-2026: 0.3%▼ -10.2% vs 12-2025 02-2026: 0.3%▲ +1.1% vs 01-2026 03-2026: 0.3%▲ +15.0% vs 02-2026 04-2026: 0.3%▲ +4.6% vs 03-2026 05-2026: 0.3%▼ -4.1% vs 04-2026 06-2026: 0.3%▼ -7.5% vs 05-2026 07-2026: 0.3%▲ +12.0% vs 06-2026 08-2026: 0.1%▼ -61.6% vs 07-2026 09-2026: 0.1%▼ -13.1% vs 08-2026lowest value 10-2026: 0.1%● 0.0% vs 09-2026lowest value
  • Sector Human health activities (NACE 86) lowers the probability
  • Negative equity -€36,782 raises the probability
  • Size: turnover €52,979, total assets €113,104 lowers the probability for this profile
  • Liquidity: current ratio 0.75, cash €96,832 lowers the probability
No credit on open account
Liquidity short (current ratio 0.75 against 0.77 in 2024; short-term debt: 132.5% and cash: 85.6% of total assets), and equity is negative.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 1%, liquidity 20%, profitability 5%, growth against the median 22%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
raises risk · Negative equity -€36,782
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Size: turnover €52,979, total assets €113,104
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.75, cash €96,832
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€36,782
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-08-2026, 15 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
15 d late
2024
9 d early
2023
75 d late
2022
24 d late
2021
29 d late
2020
45 d early
2019
16 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 10 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 24 August (4 of the last 5 filed years within 33 days of that day).
Companies Code · seven months
Position in the running window
03-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · micro…
  3. Annual accounts filedfiscal year 2023 · micro…

Key points

  • Risk: Negative equityfiscal year 2025: debts exceed assets -€36,782 View
  • Caution: Among the weakest 5% on solvencysector median 59.5% · 2,774 companies -32.5% View
  • Active since 1999founded 06-01-1999 27 years View

By topic

Financials

Fiscal year
2025
Turnover
€52,979
Loss
-€303
Solvency
-32.5%
Turnover▼ 16.4%
Net result
20242025
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 31-07-2027
  1. 15-08-2026Annual accounts filed
  2. 22-07-2025Annual accounts filed
  3. 14-10-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
06-01-1999
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure